Vaccine adjuvants based on TLR receptor ligands
US11964014B2 · kind B2 · utility
0Cited by
14References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 8, 2023 |
| Grant date | Apr 23, 2024 |
| Priority date | — |
| Expiry date | Aug 8, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16171
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Lipidated oxoadenines of formula (I) are TLR7/8 receptor ligands useful for modulating immune responses. The compounds may have therapeutic application in the treatment of cancer, infectious diseases, allergy, or autoimmune disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.